​

Funding Round

Series B - Antios Therapeutics

Series B - Antios Therapeutics

Investment Firm

Overview

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Announced Date

Nov 03, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

GordonMD Global Investments

GordonMD Global Investments

GordonMD Global Investments is a early_stage_venture and post_ipo firm.

Participant Investors

13

Investor Name
Participant InvestorGRA Venture Fund
Participant InvestorAisling Capital
Participant InvestorDomain Associates
Participant InvestorFonds de solidarité FTQ
Participant InvestorGranite Point Capital

Round Details and Background

Antios Therapeutics raised $75000000 on 2021-11-03 in Series B

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 27, 2018
Series A - Antios Therapeutics
7-25.0M
Aug 17, 2020
Venture Round - Antios Therapeutics
-4.4M
Apr 12, 2021
Series B - Antios Therapeutics
14-96.0M
Nov 03, 2021
Series B - Antios Therapeutics
20-75.0M

Recent Activity

There is no recent news or activity for this profile.